Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
about
Beyond oxidative stress: an immunologist's guide to reactive oxygen speciesShort-Term Exposure to Air Pollution and Biomarkers of Oxidative Stress: The Framingham Heart StudyHypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseasesMonocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage.Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels.Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient micePlasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease.Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy.Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.Association of blood monocyte and platelet markers with carotid artery characteristics: the atherosclerosis risk in communities carotid MRI study.Effects of interval and continuous exercise training on CD4 lymphocyte apoptotic and autophagic responses to hypoxic stress in sedentary menReduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage.Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.Metabolic fate of endogenous molecular damage: Urinary glutathione conjugates of DNA-derived base propenals as markers of inflammation.Vascular peroxidase-1 is rapidly secreted, circulates in plasma, and supports dityrosine cross-linking reactions.Effect of stilbene derivative on superoxide generation and enzyme release from human neutrophils in vitroBiochemical and pathological studies on peroxidases -an updated review.Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability.A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.Acute heart failure: patient characteristics and pathophysiology.Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.Endothelial function in a mouse model of myeloperoxidase deficiency.Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.Contrast-enhanced MRI of murine myocardial infarction - part I.Myeloperoxidase is not useful for detecting stress inducible myocardial ischemia but may be indicative of the severity of coronary artery disease.The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.Myeloperoxidase: a new twist to an old tale.Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome.Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment.An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.Nuclear transcription factor-kappa beta-dependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case-cA specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests.Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood.Analysis of myeloperoxidase activity in wound fluids as a marker of infection.
P2860
Q27011356-F26F4FF8-B5F1-401B-93A1-AEBEF70263D4Q28395707-94EF51A6-20DD-431E-A42F-98292D79B19BQ28478114-4086C0CC-BFDF-4249-810E-6E345B5D5A7EQ33473042-6D3449EB-5F5E-47D9-95FE-42DD33346D86Q33749272-755ED36A-CD87-43D8-B043-614562FB7683Q34088233-8E369909-1DFC-4292-AFA4-ADD51DE1CD66Q34236802-46C379F5-B824-4115-A293-FDA35276257DQ34541071-090CC1B6-C9B6-4063-A543-6BC3E26A6D3FQ34565544-3644954D-CACA-4302-AA4B-F1DC56636CC9Q34583092-06CFB708-B0FA-4A59-99B3-3F80AE7651C4Q34890672-B79553FC-3CE6-490D-9DA9-B39BA011720AQ34898589-8556A5F8-2DCF-4CA5-B2CE-1389486D4930Q35043935-162D3942-CA7A-43F8-B03A-AE57CD788F7AQ35207158-20A41238-1079-482B-8E8B-3EE7C0814817Q35933304-06F621DA-2612-426D-9AA3-FA345805E89FQ36055652-0C1C623A-AB8F-46C8-AAD8-324F4C72840BQ36228801-8E9DC565-6E3D-4F1E-89C1-5F25C20C760AQ36361623-DA152652-52ED-47C2-AD83-CCA953D2F7E4Q36780282-432539EE-BB28-4026-803C-9585C04922A2Q37088352-48B306CF-105E-4EFC-B9FF-CFCA25BF4081Q37228000-EE81E00D-71D3-4613-B00A-DA55252E58AAQ37281608-5A29AD41-5AB8-41D3-B50D-037FB395440DQ37297364-5CCEC85A-919A-40C4-9620-6258E3E7B47AQ37393355-ECD8957C-3287-4B3E-A1C7-7EBDB47CB7DEQ37421814-133FF338-2857-449D-B4E5-46C5CA5836B9Q37632236-258D0C89-8B82-4D92-9796-7D7B3B486E37Q37707415-26D19873-63E4-4BD1-A481-D34A4D6D0845Q37734908-F6A6FB62-61FC-44CA-B7E3-1C505065BE72Q37981643-FE822680-6FE0-45E0-925B-59DD26B3ECE7Q41896945-FE19CF3E-2236-49E3-9455-C7B2B1C896D2Q42137439-0758CE77-A5F1-40D9-A720-48F5801C5256Q42176388-DD2319AB-8404-4801-B516-428DE37A7EFEQ45800383-1116F12F-5574-4A26-BF8F-C148FAAD3C39Q46942495-96050C38-D4A1-4DA8-856F-9FE39197E17CQ47705819-228629A4-1623-435E-BCBE-54A7D552A1A0Q47885023-53096FA2-104F-497B-ABB8-4C235E49C52DQ48669544-2C940796-421F-42DE-8404-4A9931B4B78DQ48748959-631FB283-A1EF-48A9-9808-42FBC218C9D1Q50237056-D68F2B13-BD7A-44CB-98AA-308225379FC4
P2860
Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@ast
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@en
type
label
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@ast
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@en
prefLabel
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@ast
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@en
P1476
Emerging role of myeloperoxida ...... ardiovascular risk assessment.
@en
P2093
Marie-Luise Brennan
Stanley L Hazen
P304
P356
10.1097/00041433-200308000-00003
P577
2003-08-01T00:00:00Z